2012
DOI: 10.1016/j.jaad.2011.02.015
|View full text |Cite
|
Sign up to set email alerts
|

Neuropeptide Y expression in cutaneous melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(23 citation statements)
references
References 35 publications
0
22
0
1
Order By: Relevance
“…37 The elevated levels of NPY receptor have been found in breast cancer, neuroendocrine tumors, kidney cancer, prostate cancer, and some types of sarcomas. 38 Until now, SubP and NPY have not studied as biomarkers for AMI, so we validated two biomarker candidates using human serum samples of the AMI patient by analysis of the ELISA method.…”
Section: Resultsmentioning
confidence: 99%
“…37 The elevated levels of NPY receptor have been found in breast cancer, neuroendocrine tumors, kidney cancer, prostate cancer, and some types of sarcomas. 38 Until now, SubP and NPY have not studied as biomarkers for AMI, so we validated two biomarker candidates using human serum samples of the AMI patient by analysis of the ELISA method.…”
Section: Resultsmentioning
confidence: 99%
“…NPY is highly expressed in melanoma, and its expression exhibits an association with vertical growth and presence of metastasis [48]. The NPY is highly expressed in atopic skin -a stress-related condition -together with the NGF which has been also associated with psychological stress [49].…”
Section: Neuropeptide Y (Npy)mentioning
confidence: 99%
“…including neuroblastoma, [52] breast cancer, [53] pancreatic ductal adenocarcinoma, [54] and colon cancer. [55,56] Inflammation (inflammatory bowel disease)-induced nuclear factor-kappa B (NF-B) activation up-regulates the level of netrin-1, which is reported to be not only involved in colorectal tumor promotion and progression but also associated with worse outcome in poorly differentiated pancreatic adenocarcinoma. [57][58][59] Surprisingly, netrin-1 also plays a key role in improving pancreatic and pulmonary injury and possesses anti-inflammatory capability by inhibiting leukocyte infiltration in mice with severe acute pancreatitis, which may provide important clues for identifying novel treatment targets for pancreatitis and even pancreatic cancer.…”
Section: Introductionmentioning
confidence: 99%
“…NPY receptors including Y1, Y2, and Y5 are expressed in various types of cancers, such as pancreatic, breast, ovarian cancers, and neuroblastoma. [64][65][66][67] The actions of NPY/NPY receptors in cancer progression are dependent on cancer type or receptor type. Y1 receptor is predominantly expressed in human breast cancer, while Y2 receptor is preferentially expressed in normal human breast cells.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation